Our Services

We prescribe Semaglutide and Tirzepatide compound medications.

Semaglutide is a GLP-1 receptor agonists that delays gastric emptying therefore making you feel full faster and decreases appetite. When combined with a calorie-restricted diet and regular physical activity this medication has shown significant weight loss benefits for many people. If you have been struggling with obesity and having difficulties losing weight, this may be the medication for you. This medication is taken once weekly as a subcutaneous injection.

Tirzepatide is a GLP-1/GIP receptor agonists that delays gastric emptying therefore making you feel full faster and it also works on the brain to decrease cravings. Tirzepatide has demonstrated significant reductions in body weight. If you have been struggling with obesity and having difficulties losing weight, this may be the medication for you. This medication is taken once weekly as a subcutaneous injection.

Compounded drugs are not FDA-approved. This means the FDA does not verify the safety or effectiveness of compounded drugs.

Risks associated with compounded medications:

Because compounded drugs are not FDA-approved, the FDA does not verify their effectiveness, safety or quality before they are marketed. Compounded drugs can serve an important medical need for patients, but they do not have the same quality, safety and effectiveness assurances as approved drugs. Unnecessary use of compounded drugs can potentially expose patients to serious health risks. Poor compounding practices can result in serious drug quality problems, such as contamination or a drug that contains too much active ingredient. This can lead to serious injury or death. Compounding drugs under unsanitary conditions could lead to widespread patient harm, especially when the compounder engages in large-scale, non-patient specific compounding and distribution. The FDA may not be aware of which compounders are making such drugs and some states may have insufficient resources to adequately oversee them.

Warnings

DO NOT take Semaglutide or Tirzepatide if:

  • You are pregnant, breast feeding or attempting to become pregnant

  • Have a history of pancreatitis

  • Have a history of Multiple Endocrine Neoplasia Type II (MEN 2)

  • Have a history of suicidal thoughts or severe depression

  • If you or any of your family have ever had a type of thyroid cancer called Medullary thyroid carcinoma (MTC)

  • If you are allergic to it or any of the ingredients in the medication

Semaglutide and Tirzepatide may cause the following:

  • Pancreatitis

  • Nausea/Vomiting/Diarrhea/Constipation

  • Abdominal pain and cramping

  • Headaches/Dizziness

  • Ileus/Gastroparesis

  • Acute Gallbladder problems

  • Acute kidney problems

  • Vision problems in people with type 2 diabetes

  • Depression or thoughts of suicide

  • Upset stomach

  • Heartburn

  • Low blood sugar (hypoglycemia) in people with type 2 diabetes